Deregulation of Pine Shoot Beetle

by the Animal and Plant Health Inspection Service on 10/01/2020.

We are adopting as a final rule, without change, a proposal to amend our regulations to remove the domestic pine shoot beetle (PSB) quarantine and to eliminate the restrictions that apply to the importation of PSB host material from Canada. We have determined through analysis that the regulatory program is ineffective in slowing the spread of...

Notice of Request for Revision to and Extension of Approval of an Information Collection; Importation of Live Swine, Pork and Pork Products, and Swine Semen From the European Union

by the Animal and Plant Health Inspection Service on 10/01/2020.

In accordance with the Paperwork Reduction Act of 1995, this notice announces the Animal and Plant Health Inspection Service's intention to request a revision to and extension of approval of an information collection associated with regulations for the importation of live swine, pork and pork products, and swine semen from the European Union.

Notice of Public Meeting of the Pennsylvania Advisory Committee

by the Civil Rights Commission on 10/01/2020.

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission), and the Federal Advisory Committee Act (FACA) that two meetings of the Pennsylvania Advisory Committee to the Commission will convene by conference calls, as noted below. The purpose of both planning meetings is to...

Notice of Public Meeting of the California Advisory Committee

by the Civil Rights Commission on 10/01/2020.

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act (FACA) that a meeting of the California Advisory Committee (Committee) to the Commission will be held at 2:00 p.m. (Pacific) on Wednesday, October 7, 2020. The purpose of the...

Notice of Public Meeting of the Hawai'i Advisory Committee

by the Civil Rights Commission on 10/01/2020.

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act (FACA) that a teleconference meeting of the Hawai'i Advisory Committee (Committee) to the Commission will be held at 10:00 a.m. on Friday, October 16, 2020 (Hawaiian Time). The...

Notice of Public Meeting of the Maine Advisory Committee to the U.S. Commission on Civil Rights

by the Civil Rights Commission on 10/01/2020.

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act that the Maine Advisory Committee (Committee) will hold a meeting on Thursday, October 15, 2020, at 12:00 p.m. (EDT) for the purpose of meeting is to discuss next steps for its...

Notice of Public Meeting of the Wyoming Advisory Committee

by the Civil Rights Commission on 10/01/2020.

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act (FACA) that a teleconference meeting of the Wyoming Advisory Committee (Committee) to the Commission will be held at 1:00 p.m. (MDT) Thursday, October 22, 2020. The purpose of...

President's Advisory Commission on Hispanic Prosperity

by the Education Department on 10/01/2020.

This notice sets forth the agenda, time, and instructions for public participation in the September 30, 2020 meeting of the President's Advisory Commission on Hispanic Prosperity (Commission) and provides information to members of the public regarding the meeting. Notice of this meeting is required under Section 10(a)(2) of the Federal Advisory...

Agency Forms Undergoing Paperwork Reduction Act Review

by the Centers for Disease Control and Prevention on 10/01/2020.

Proposed Data Collection Submitted for Public Comment and Recommendations

by the Centers for Disease Control and Prevention on 10/01/2020.

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of...

Medicare Program; Approval of Application by The Compliance Team for Initial CMS-Approval of its Home Infusion Therapy Accreditation Program; Correction

by the Centers for Medicare & Medicaid Services on 10/01/2020.

This document corrects a technical error that appeared in the final notice published in the Federal Register on September 28, 2020 entitled ``Medicare Program; Approval of Application by The Compliance Team for Initial CMS-Approval of Its Home Infusion Therapy Accreditation Program.''

Importation of Certain Food and Drug Administration-Approved Human Prescription Drugs, Including Biological Products, and Combination Products Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability

by the Food and Drug Administration on 10/01/2020.

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled ``Importation of Certain FDA-Approved Human Prescription Drugs, Including Biological Products, and Combination Products under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act.'' This guidance describes...

Office of the Assistant Secretary for Planning and Evaluation; Medicaid Reentry Stakeholder Group

by the Health and Human Services Department on 10/01/2020.

The Secretary of HHS has determined that establishment of the Medicaid Reentry Stakeholder Group, as required by the Medicaid Reenty Act, is desirable to provide advice and consultation to the Secretary on innovative strategies to help individuals who are inmates of public institutions, and otherwise eligible for Medicaid, ensure continuity of...

National Heart, Lung, and Blood Institute; Notice of Meeting

by the National Institutes of Health on 10/01/2020.

National Human Genome Research Institute; Notice of Closed Meeting

by the National Institutes of Health on 10/01/2020.

Government-Owned Inventions; Availability for Licensing

by the National Institutes of Health on 10/01/2020.

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. to achieve expeditious commercialization of results of federally-funded research and development.

Government-Owned Inventions; Availability for Licensing

by the National Institutes of Health on 10/01/2020.

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research and development.

Prospective Grant of an Exclusive Patent License: Allogeneic Therapy Using an Armored Payload and Chimeric Antigen Receptors Targeting GPC3

by the National Institutes of Health on 10/01/2020.

The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Senti Biosciences, Inc....

National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

by the National Institutes of Health on 10/01/2020.

Government-Owned Inventions; Availability for Licensing

by the National Institutes of Health on 10/01/2020.

The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.